Scientists test new drug duo in fight against tough cancers
NCT ID NCT02211755
Summary
This early-stage study tested the safety of combining two cancer drugs, bortezomib and clofarabine, in adults with advanced solid tumors, lymphomas, or blood disorders that had stopped responding to standard treatments. The main goal was to find the highest dose patients could tolerate without severe side effects. Researchers also took tissue and blood samples to learn how the drugs might affect cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.